This issue of Cardiac Electrophysiology Clinics, Guest Edited by Drs. Mohammad Shenasa, Prashanthan Sanders, and Stanley Nattel, is dedicated to Risk Factors in Atrial Fibrillation: Appraisal of AF Risk Stratification. This is one of four issues selected each year by the series Consulting Editors, Ranjan K. Thakur and Andrea Natale. Topics include, but are not limited to, Epidemiology of Atrial Fibrillation; Hypertension, Prehypertension, Hypertensive Heart Disease and Atrial Fibrillation; Pulmonary Disease, Pulmonary Hypertension and Atrial Fibrillation; Heart Failure with Preserved (HFpEF) and Reduced (HFrEF) LV Systolic Function, Diastolic Dysfunction; Coronary Artery Disease; ECG and Echo Abnormalities in Patients with Atrial Fibrillation Risk Factors; Diabetes and Endocrine Disorders; Obesity and Metabolic Syndrome in Atrial Fibrillation; Renal Disease; Sleep Apnea and Atrial Fibrillation; Channelopathies in Atrial Fibrillation; Implications of Inflammation and Myocardial Fibrosis in Atrial Fibrillation; Role of Biomarkers in Atrial Fibrillation; Left Ventricular Hypertrophy and Other Cardiomyopathies in Atrial Fibrillation; Atrial Fibrillation in Valvular Heart Disease; Atrial Fibrillation in Adult Congenital Heart Disease; Exercise and Athletic Activity in Atrial Fibrillation; Post-op Atrial Fibrillation; Autonomic Dysfunction and Neurohormonal Disorders in Atrial Fibrillation; Social Risk Factors; Atrial Fibrillation and Stroke; Screening for Atrial Fibrillation Risk Factors; Primary Care and Internists Perspective on Atrial Fibrillation Risk Factors; and Lifestyle as a Risk Factor for Atrial Fibrillation.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xvi 7. Foreword - p. xvii 8. Preface - p. xix 9. Epidemiology of Atrial Fibrillation: Geographic/Ecological Risk Factors, Age, Sex, Genetics - p. 1 10. Implications of Inflammation and Fibrosis in Atrial Fibrillation Pathophysiology - p. 25 11. Risk Factors - p. 35 12. Hypertension, Prehypertension, Hypertensive Heart Disease, and Atrial Fibrillation - p. 37 13. Atrial Fibrillation and Heart Failure: Epidemiology, Pathophysiology, Prognosis, and Management - p. 47 14. Diabetes and Endocrine Disorders (Hyperthyroidism/Hypothyroidism) as Risk Factors for Atrial Fibrillation - p. 63 15. Obesity and Metabolic Syndrome in Atrial Fibrillation: Cardiac and Noncardiac Adipose Tissue in Atrial Fibrillation - p. 77 16. Sleep Apnea and Atrial Fibrillation - p. 87 17. Renal Disease and Atrial Fibrillation - p. 95 18. Atrial Fibrillation in Valvular Heart Disease - p. 113 19. Postoperative Atrial Fibrillation: Features, Mechanisms, and Clinical Management - p. 123 20. Post–Cardiac Surgery Atrial Fibrillation: Risks, Mechanisms, Prevention, and Management - p. 133 21. Pulmonary Disease, Pulmonary Hypertension and Atrial Fibrillation - p. 141 22. Atrial Fibrillation in Inherited Channelopathies - p. 155 23. Social Risk Factors and Atrial Fibrillation - p. 165 24. Exercise and Athletic Activity in Atrial Fibrillation - p. 173 25. Autonomic Dysfunction and Neurohormonal Disorders in Atrial Fibrillation - p. 183 26. Pathophysiology, Risk Factors, and Management of Atrial Fibrillation in Adult Congenital Heart Disease - p. 191 27. Risk Factors for Atrial Fibrillation Progression - p. 201 28. Diagnostic Tests - p. 209 29. Electrocardiographic and Echocardiographic Abnormalities in Patients with Risk Factors for Atrial Fibrillation - p. 211 30. Biomarkers in Atrial Fibrillation: Pathogenesis and Clinical Implications - p. 221 31. Is Screening for Atrial Fibrillation and Its Risk Factors Useful and Cost-Effective? - p. 235 32. Atrial Fibrillation and Stroke - p. 243 33. A Team-Based Approach Toward Risk Factors of Atrial Fibrillation - p. 257 34. Lifestyle as a Risk Factor for Atrial Fibrillation - p. 263
This issue of Cardiac Electrophysiology Clinics, Guest Edited by Drs. Mohammad Shenasa, Prashanthan Sanders, and Stanley Nattel, is dedicated to Risk Factors in Atrial Fibrillation: Appraisal of AF Risk Stratification. This is one of four issues selected each year by the series Consulting Editors, Ranjan K. Thakur and Andrea Natale. Topics include, but are not limited to, Epidemiology of Atrial Fibrillation; Hypertension, Prehypertension, Hypertensive Heart Disease and Atrial Fibrillation; Pulmonary Disease, Pulmonary Hypertension and Atrial Fibrillation; Heart Failure with Preserved (HFpEF) and Reduced (HFrEF) LV Systolic Function, Diastolic Dysfunction; Coronary Artery Disease; ECG and Echo Abnormalities in Patients with Atrial Fibrillation Risk Factors; Diabetes and Endocrine Disorders; Obesity and Metabolic Syndrome in Atrial Fibrillation; Renal Disease; Sleep Apnea and Atrial Fibrillation; Channelopathies in Atrial Fibrillation; Implications of Inflammation and Myocardial Fibrosis in Atrial Fibrillation; Role of Biomarkers in Atrial Fibrillation; Left Ventricular Hypertrophy and Other Cardiomyopathies in Atrial Fibrillation; Atrial Fibrillation in Valvular Heart Disease; Atrial Fibrillation in Adult Congenital Heart Disease; Exercise and Athletic Activity in Atrial Fibrillation; Post-op Atrial Fibrillation; Autonomic Dysfunction and Neurohormonal Disorders in Atrial Fibrillation; Social Risk Factors; Atrial Fibrillation and Stroke; Screening for Atrial Fibrillation Risk Factors; Primary Care and Internists Perspective on Atrial Fibrillation Risk Factors; and Lifestyle as a Risk Factor for Atrial Fibrillation.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xvi 7. Foreword - p. xvii 8. Preface - p. xix 9. Epidemiology of Atrial Fibrillation: Geographic/Ecological Risk Factors, Age, Sex, Genetics - p. 1 10. Implications of Inflammation and Fibrosis in Atrial Fibrillation Pathophysiology - p. 25 11. Risk Factors - p. 35 12. Hypertension, Prehypertension, Hypertensive Heart Disease, and Atrial Fibrillation - p. 37 13. Atrial Fibrillation and Heart Failure: Epidemiology, Pathophysiology, Prognosis, and Management - p. 47 14. Diabetes and Endocrine Disorders (Hyperthyroidism/Hypothyroidism) as Risk Factors for Atrial Fibrillation - p. 63 15. Obesity and Metabolic Syndrome in Atrial Fibrillation: Cardiac and Noncardiac Adipose Tissue in Atrial Fibrillation - p. 77 16. Sleep Apnea and Atrial Fibrillation - p. 87 17. Renal Disease and Atrial Fibrillation - p. 95 18. Atrial Fibrillation in Valvular Heart Disease - p. 113 19. Postoperative Atrial Fibrillation: Features, Mechanisms, and Clinical Management - p. 123 20. Post–Cardiac Surgery Atrial Fibrillation: Risks, Mechanisms, Prevention, and Management - p. 133 21. Pulmonary Disease, Pulmonary Hypertension and Atrial Fibrillation - p. 141 22. Atrial Fibrillation in Inherited Channelopathies - p. 155 23. Social Risk Factors and Atrial Fibrillation - p. 165 24. Exercise and Athletic Activity in Atrial Fibrillation - p. 173 25. Autonomic Dysfunction and Neurohormonal Disorders in Atrial Fibrillation - p. 183 26. Pathophysiology, Risk Factors, and Management of Atrial Fibrillation in Adult Congenital Heart Disease - p. 191 27. Risk Factors for Atrial Fibrillation Progression - p. 201 28. Diagnostic Tests - p. 209 29. Electrocardiographic and Echocardiographic Abnormalities in Patients with Risk Factors for Atrial Fibrillation - p. 211 30. Biomarkers in Atrial Fibrillation: Pathogenesis and Clinical Implications - p. 221 31. Is Screening for Atrial Fibrillation and Its Risk Factors Useful and Cost-Effective? - p. 235 32. Atrial Fibrillation and Stroke - p. 243 33. A Team-Based Approach Toward Risk Factors of Atrial Fibrillation - p. 257 34. Lifestyle as a Risk Factor for Atrial Fibrillation - p. 263
